BiotechTube
Home/Pipeline/iPSC Platform Programs

iPSC Platform Programs

Neurological Disorders

Preclinical ResearchActive

Key Facts

Indication
Neurological Disorders
Phase
Preclinical Research
Status
Active
Company
Evotec

About Evotec

Evotec has evolved from a traditional CRO into a technology-enabled, fully integrated drug discovery and development partner. Its strategy leverages proprietary platforms like PanOmics and iPSC disease modeling, alongside flexible partnership models, to serve the entire Top 20 pharma and over 800 biotechs. Through its Just – Evotec Biologics division, it is also redefining biologics manufacturing with continuous processing to improve accessibility and affordability of therapies.

View full company profile

Therapeutic Areas

OncologyNeurologyImmunologyCardiovascular & Metabolic Diseases

Other Neurological Disorders Drugs

DrugCompanyPhase
Biomarker Development ProgramNeuroVision ImagingResearch
GlyT2 Inhibitor ProgramMicar InnovationDiscovery
Biomarker Discovery & Validation ServicesNeuroDexService
Clinical Trial Biomarker SupportNeuroDexService
CNS-Targeting CapsidsrAAVen TherapeuticsPre-clinical
IVL-002InVirtuoLabsDiscovery
IVL-003InVirtuoLabsDiscovery
Neurology Diagnostics ProgramAptus BiosciencesDiscovery
GM1 Ganglioside-based TherapiesTRB Chemedica InternationalCommercial / Development
Undisclosed Neurology ProgramsBridGene BiosciencesDiscovery
ExacTcell PlatformTevogen BioDiscovery/Preclinical